Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Campion

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Medical Oncology (Northwood, London, England)|August 28, 2016
Stereotactic ablative radiotherapy in the treatment of hepatocellular carcinoma >3 cmAlessia Guarneri, Pierfrancesco Franco, Elisabetta Trino, et al.
Journal of Hepatology|October 21, 2023
A prospective, multicenter, three-cohort study evaluating contrast-induced acute kidney injury (CI-AKI) in patients with cirrhosisDaniela Campion, Paola Ponzo, Alessandro Risso, et al.
Journal of Hepatology|September 8, 2020
Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope ConsortiumElsa Solà, Elisa Pose, Daniela Campion, et al.
The Lancet. Gastroenterology & Hepatology|October 15, 2019
Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trialElisa Pose, Laura Napoleone, Ahmed Amin, et al.
Hepatology Communications|December 29, 2021
Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated CirrhosisElisa Pose, Elsa Solà, Juan J Lozano, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 9, 2019
Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial PeritonitisJavier Fernández, Paolo Angeli, Jonel Trebicka, et al.
Gut|October 26, 2023
Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysisAdrià Juanola, Ann Thu Ma, Koos de Wit, et al.
Journal of Hepatology|November 29, 2019
Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLFRichard Moreau, Joan Clària, Ferran Aguilar, et al.
JAMA|February 5, 2025
Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical TrialElisa Pose, César Jiménez, Giacomo Zaccherini, et al.
JHEP Reports : Innovation in Hepatology|July 21, 2025
Long-term effectiveness, safety, and liver stiffness dynamics of PBC treatment with obeticholic acid in real-worldFrancesca Terracciani, Antonio De Vincentis, Daphne D'Amato, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Medical Oncology (Northwood, London, England)|August 28, 2016
Stereotactic ablative radiotherapy in the treatment of hepatocellular carcinoma >3 cmAlessia Guarneri, Pierfrancesco Franco, Elisabetta Trino, et al.
Journal of Hepatology|October 21, 2023
A prospective, multicenter, three-cohort study evaluating contrast-induced acute kidney injury (CI-AKI) in patients with cirrhosisDaniela Campion, Paola Ponzo, Alessandro Risso, et al.
Journal of Hepatology|September 8, 2020
Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope ConsortiumElsa Solà, Elisa Pose, Daniela Campion, et al.
The Lancet. Gastroenterology & Hepatology|October 15, 2019
Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trialElisa Pose, Laura Napoleone, Ahmed Amin, et al.
Hepatology Communications|December 29, 2021
Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated CirrhosisElisa Pose, Elsa Solà, Juan J Lozano, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 9, 2019
Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial PeritonitisJavier Fernández, Paolo Angeli, Jonel Trebicka, et al.
Gut|October 26, 2023
Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysisAdrià Juanola, Ann Thu Ma, Koos de Wit, et al.
Journal of Hepatology|November 29, 2019
Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLFRichard Moreau, Joan Clària, Ferran Aguilar, et al.
JAMA|February 5, 2025
Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical TrialElisa Pose, César Jiménez, Giacomo Zaccherini, et al.
JHEP Reports : Innovation in Hepatology|July 21, 2025
Long-term effectiveness, safety, and liver stiffness dynamics of PBC treatment with obeticholic acid in real-worldFrancesca Terracciani, Antonio De Vincentis, Daphne D'Amato, et al.
Pageof 2